Camrelizumab increased the 3-year event-free survival rate vs standard of care from 77.3% to 86.9%, translating to a 44% ...

Many Americans are unaware of the connection between drinking and cancer risk, despite growing research that points to the ...

A Spain-based startup has successfully demonstrated the capability of its graphene-based brain-computer interface (BCI) ...

The FDA received an application for Nubeqa as a potential treatment option with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.

Drenching night sweats are a serious symptom that sets off my internal alarm bells, so please go see your doctor right away. Finally, new urinary symptoms with spinal stenosis need to be evaluated, ...

News 8's Brennan Somers speaks to the organizers of Comics Against Cancer, now returning for its second year this October!

Newcastle United CEO Darren Eales will step down from his position after being diagnosed with a chronic form of blood cancer, the Premier League club said on Friday.

Genelux Corporation is at the forefront of developing oncolytic immunotherapies. Its lead candidate, olvimulogene ...

OCRA’s approach to prevention is groundbreaking, combining genetic testing with recommendations on preventive surgical ...

Cancer death rates have fallen by 25% since the turn of the century. Stage 4 cancer diagnoses — previously considered death ...

Scientists have successfully grown a tree from a 1,000-year-old seed with some speculating that this could be the long lost ...

Per Genentech, the current price of Herceptin for a patient with “HER2 positive metastatic breast cancer” as about $50,000, a ...